Allergy Therapeutics Takes First Steps Into Broader Vaccine Field
Licensing Agreement Signed With Saiba And DeepVax
Executive Summary
Allergy Therapeutics is keen to extend its early R&D pipeline into non-allergy areas through extending its tie-up with Saiba and DeepVax on their virus-like particle technology.